Therapy of invasive bladder cancer (Q36418401)

14 August 2017

1 reference

title

Therapy of invasive bladder cancer (English)

1 reference

14 August 2017

Colin P N Dinney

1

1 reference

14 August 2017

language of work or name

English

0 references

publication date

1 March 2006

1 reference

14 August 2017

1 reference

14 August 2017

volume

67

1 reference

14 August 2017

issue

3 Suppl 1

1 reference

14 August 2017

page(s)

56-9; discussion 60-1

1 reference

Genetic studies and molecular markers of bladder cancer

14 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.01.043

Accumulation of nuclear p53 and tumor progression in bladder cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.01.043

p53 and treatment of bladder cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.01.043

Prognostic value of p53 nuclear overexpression in patients with invasive bladder cancer treated with neoadjuvant MVAC

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.01.043

Predicting the survival of bladder carcinoma patients treated with radical cystectomy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.01.043

Correlation between annual volume of cystectomy, professional staffing, and outcomes: a statewide, population-based study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.01.043

Selective bladder preservation for muscle-invasive transitional cell carcinoma of the urinary bladder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.01.043

Integrated therapy for locally advanced bladder cancer: final report of a randomized trial of cystectomy plus adjuvant M-VAC versus cystectomy with both preoperative and postoperative M-VAC

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.01.043

Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.01.043

Surgical factors influence bladder cancer outcomes: a cooperative group report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.01.043

Perioperative chemotherapy in locally advanced bladder cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.01.043

Is there a role for surgery in the management of metastatic urothelial cancer? The M. D. Anderson experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.01.043

Is there a therapeutic role for post-chemotherapy retroperitoneal lymph node dissection in metastatic transitional cell carcinoma of the bladder?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.01.043

Preliminary results of M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for transitional cell carcinoma of the urothelium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.01.043

Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: results of a large, randomized, multinational, multicenter, phase III study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.01.043

10.1016/J.UROLOGY.2006.01.043

7 January 2021

Identifiers

DOI

1 reference

14 August 2017

1 reference